![Antony Mattessich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Antony Mattessich
Direttore/Membro del Consiglio presso AURA BIOSCIENCES, INC.
Patrimonio netto: 1 M $ in data 31/05/2024
Profilo
Antony Mattessich is an Independent Non-Executive Director at Aura Biosciences, Inc. He previously served as President, Chief Executive Officer & Director at Mundipharma International Ltd.
from 2009 to 2017.
From 2017 to 2024, he held the same positions at Ocular Therapeutix, Inc. Prior to that, he was the Managing Director & Director at Napp Pharmaceutical Holdings Ltd.
from 2005 to 2011.
Antony also worked at Bristol Myers Squibb Co. as the Head of Operations-International Medicines.
Before that, he was the Head-Therapeutic Franchise at Novartis AG from 2003 to 2005.
Antony completed his graduate degree at The Trustees of Columbia University in The City of New York and his undergraduate degree at the University of California, Berkeley.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
OCULAR THERAPEUTIX INC
0.15% | 31/03/2024 | 235 018 ( 0.15% ) | 1 M $ | 31/05/2024 |
AURA BIOSCIENCES INC
0.02% | 20/06/2024 | 10 500 ( 0.02% ) | 77 175 $ | 31/05/2024 |
Posizioni attive di Antony Mattessich
Società | Posizione | Inizio |
---|---|---|
AURA BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 29/09/2021 |
Precedenti posizioni note di Antony Mattessich
Società | Posizione | Fine |
---|---|---|
OCULAR THERAPEUTIX, INC. | Amministratore Delegato | 15/04/2024 |
Mundipharma International Ltd.
![]() Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Amministratore Delegato | 18/12/2017 |
Napp Pharmaceutical Holdings Ltd.
![]() Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Amministratore Delegato | 01/05/2011 |
NOVARTIS AG | Corporate Officer/Principal | 01/01/2005 |
BRISTOL-MYERS SQUIBB COMPANY | Direttore/Membro del Consiglio | - |
Formazione di Antony Mattessich
The Trustees of Columbia University in The City of New York | Graduate Degree |
University of California, Berkeley | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
OCULAR THERAPEUTIX, INC. | Health Technology |
NOVARTIS AG | Health Technology |
AURA BIOSCIENCES, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Aziende private | 2 |
---|---|
Napp Pharmaceutical Holdings Ltd.
![]() Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Mundipharma International Ltd.
![]() Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Antony Mattessich